Abdera Therapeutics

#JPM26 was a meaningful opportunity to share our progress and vision for advancing next-generation #radiotherapeutics. With continued execution of ABD-147 and ABD-320, our growing pipeline reflects a clear focus on patients and an exciting path ahead for what our science could make possible. 

The holiday season offers a moment to pause and take stock of the work that matters. We’re grateful for the dedication behind our radiopharmaceutical programs and for the shared commitment to advancing new options for patients. Wishing our colleagues, partners, and the broader community a joyful holiday season, and Happy New Year!

From clinical progress to what’s ahead, Abdera CEO Lori Lyons-Williams will provide an overview of the company and our pipeline of first-in-class radiotherapeutics, including ABD-147 and ABD-320, at #JPM26. Guided by our mission to develop precision radiopharmaceuticals with the potential to transform #cancer care, we look forward to sharing how we’re advancing these programs toward patients. Details: https://lnkd.in/gh4CdEJf

‘Tis the grateful season! From all of us at #TeamAbdera, we wish you a #Thanksgiving filled with gratitude and appreciation. We’re especially thankful for our dedicated team that’s the driving force behind Abdera’s innovation and gives us this opportunity to contribute to a mission focused on helping others.

Lung cancer remains the leading cause of cancer-related deaths in the U.S., but early screening can improve five-year survival rates to 65%. This #LungCancerAwarenessMonth, we recognize the importance of early detection, stand with those affected, and celebrate the progress being made to defeat this disease. At Abdera, we’re committed to advancing innovation in #radiotherapeutics to help change the future of #cancer care, and we’re with you every step of the way.

From Vancouver to San Francisco, #TeamAbdera brought the fun this #Halloween! With Mario Kart characters, space cadets, a cat lady, and many more, our teams showed off their creativity and a few spooky surprises. Take a look at some of the standout costumes and pumpkins from this year’s celebration.

Abdera leadership will be participating in multiple investor conferences this November. We look forward to sharing how our proprietary ROVEr platform is driving the design and development of tunable precision #radiopharmaceuticals to bring new hope to people living with cancer.

Abdera Chief Technical Officer Kawa C. will speak on an upcoming Women In Bio - Engage. Educate. Empower. panel discussion to explore the latest breakthroughs in precision oncology and their potential to reshape how we treat #cancer. Join Kawa as she represents Abdera’s commitment to advancing targeted #radiotherapeutics and shares her perspective on the future of oncology innovation. Learn more and register here: https://lnkd.in/gvD9_KCS

We’re looking forward to next week’s Longwood Healthcare Leaders Boston CEO event, where CEO Lori Lyons-Williams will join industry leaders to share insights and drive conversations that matter for patients. Details below.

The Abdera team sends warm wishes to our team and community in Canada this Thanksgiving! May your holiday be filled with gratitude, connection, and the simple joys that make this season special.